| Adolescent rats find repeated Δ9-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure HR Quinn, I Matsumoto, PD Callaghan, LE Long, JC Arnold, ... Neuropsychopharmacology 33 (5), 1113-1126, 2008 | 342 | 2008 |
| The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors T Bakas, PS Van Nieuwenhuijzen, SO Devenish, IS McGregor, JC Arnold, ... Pharmacological research 119, 358-370, 2017 | 250 | 2017 |
| Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile W Swift, A Wong, KM Li, JC Arnold, IS McGregor PloS one 8 (7), e70052, 2013 | 239 | 2013 |
| A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice LE Long, R Chesworth, XF Huang, IS McGregor, JC Arnold, T Karl International Journal of Neuropsychopharmacology 13 (7), 861-876, 2010 | 235 | 2010 |
| Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats C Klein, E Karanges, A Spiro, A Wong, J Spencer, T Huynh, ... Psychopharmacology 218, 443-457, 2011 | 233 | 2011 |
| Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses MS Kassem, J Lagopoulos, T Stait-Gardner, WS Price, TW Chohan, ... Molecular neurobiology 47, 645-661, 2013 | 212 | 2013 |
| Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol AA Boucher, JC Arnold, L Duffy, PR Schofield, J Micheau, T Karl Psychopharmacology 192, 325-336, 2007 | 209 | 2007 |
| Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats MT Bowen, DS Carson, A Spiro, JC Arnold, IS McGregor PloS one 6 (11), e27237, 2011 | 159 | 2011 |
| The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids ML Holland, DTT Lau, JD Allen, JC Arnold British journal of pharmacology 152 (5), 815-824, 2007 | 157 | 2007 |
| The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells ML Holland, JA Panetta, JM Hoskins, M Bebawy, BD Roufogalis, JD Allen, ... Biochemical pharmacology 71 (8), 1146-1154, 2006 | 155 | 2006 |
| Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus DS Carson, GE Hunt, AJ Guastella, L Barber, JL Cornish, JC Arnold, ... Addiction biology 15 (4), 448-463, 2010 | 154 | 2010 |
| Low-dose midazolam attenuates predatory odor avoidance in rats RA Dielenberg, JC Arnold, IS McGregor Pharmacology Biochemistry and Behavior 62 (2), 197-201, 1999 | 128 | 1999 |
| Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test AA Boucher, JC Arnold, GE Hunt, A Spiro, J Spencer, C Brown, ... Neuroscience 189, 170-177, 2011 | 126 | 2011 |
| Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions LL Anderson, NL Absalom, SV Abelev, IK Low, PT Doohan, LJ Martin, ... Epilepsia 60 (11), 2224-2234, 2019 | 122 | 2019 |
| Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1) ML Holland, JD Allen, JC Arnold European journal of pharmacology 591 (1-3), 128-131, 2008 | 114 | 2008 |
| Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors M Santiago, S Sachdev, JC Arnold, IS McGregor, M Connor Cannabis and cannabinoid research 4 (3), 165-176, 2019 | 112 | 2019 |
| Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice LE Long, R Chesworth, XF Huang, A Wong, A Spiro, IS McGregor, ... PloS one 7 (4), e34129, 2012 | 112 | 2012 |
| Reintoxication: the release of fat‐stored Δ9‐tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure N Gunasekaran, LE Long, BL Dawson, GH Hansen, DP Richardson, ... British journal of pharmacology 158 (5), 1330-1337, 2009 | 105 | 2009 |
| Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) N Lintzeris, L Mills, A Suraev, M Bravo, T Arkell, JC Arnold, MJ Benson, ... Harm reduction journal 17, 1-12, 2020 | 97 | 2020 |
| Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome LL Anderson, IK Low, SD Banister, IS McGregor, JC Arnold Journal of natural products 82 (11), 3047-3055, 2019 | 96 | 2019 |
Iain S. McGregorUniversity of SydneyVerified email at sydney.edu.au
